Wei Pan

Title: Wei Pan: Innovator in Gene Editing and Immunotherapy

Introduction

Wei Pan is a prominent inventor based in Philadelphia, PA, known for his significant contributions to the field of gene editing and immunotherapy. With a focus on developing advanced therapeutic techniques, he has been instrumental in creating innovative solutions for cancer treatment.

Latest Patents

Wei Pan holds 2 patents that showcase his groundbreaking work. His latest patents include the use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapy. This invention encompasses compositions and methods for a modified immune cell or precursor cell that includes an inducible expression system. Additionally, the patents provide gene-edited modified immune cells suitable for T cell therapy, along with methods of treatment using these modified immune cells.

Career Highlights

Wei Pan is affiliated with the University of Pennsylvania, where he continues to advance research in immunotherapy. His work has garnered attention for its potential to revolutionize cancer treatment through innovative gene editing techniques.

Collaborations

Throughout his career, Wei Pan has collaborated with notable colleagues, including Yangbing Zhao and Xiaojun Liu. These partnerships have further enhanced the impact of his research and innovations in the field.

Conclusion

Wei Pan's contributions to gene editing and immunotherapy represent a significant advancement in medical science. His innovative patents and ongoing research at the University of Pennsylvania continue to pave the way for new therapeutic approaches in cancer treatment.